Bethesda, Maryland
CNS clinical trials in Bethesda, MD
54 CNS studies are recruiting participants at sites in Bethesda as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Bethesda at a glance
- 54 studies are recruiting at a site in Bethesda.
- By phase: Phase 1 (8), Phase 1/2 (2), Phase 2 (6), Phase 3 (5), No phase (3), Observational (30). Studies of devices and behavioral approaches have no phase.
- By sponsor: government (43), industry (8), university, hospital or other (3).
- By research area: Depression (14), Epilepsy (14), Multiple Sclerosis (14), ADHD (5), Parkinson's Disease (5), Bipolar Disorder (1), Migraine (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Bethesda
Basic details from each study's public record (the 30 most recently updated of 54). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- Phase 2
- Ages 8 to 65
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00018057 · updated
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- Phase 1
- Ages 18 to 70
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT03973268 · updated
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- Phase 1
- Ages 18 to 65
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT03065335 · updated
Natural History of Depression, Bipolar Disorder and Suicide Risk
- Observational
- Ages 18 to 120
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT06462196 · updated
Characterization and Treatment of Adolescent Depression
- Observational
- Ages 11 to 25
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT03388606 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Bethesda, MD on ClinicalTrials.gov.
ADHD studies recruiting in Bethesda
Developing Brain, Impulsivity and Compulsivity
- Observational
- Ages 6 to 80
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT04631042 · updated
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
- Observational
- Ages 8 to 17
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT07640802 · updated
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
- Observational
- Ages 8 to 13
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT07764536 · updated
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- Phase 1/2
- Ages 8 to 16
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT05608434 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Bethesda, MD on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Bethesda
Deep Brain Stimulation Surgery for Movement Disorders
- No phase
- Ages 18 to 99
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT01581580 · updated
Deep Brain Stimulation Therapy in Movement Disorders
- No phase
- Ages 18 to 100
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT02119611 · updated
Evaluation and Treatment of Neurosurgical Disorders
- Observational
- Ages 4 to 99
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00060541 · updated
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT04396873 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Bethesda, MD on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Bethesda
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- Observational
- From 1 month, up to 99 years
- All sexes
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00794352 · updated
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- National Cancer Institute Developmental Therapeutics Clinic
- Registry record
- NCT03816345 · updated
Role of Genetic Factors in the Development of Lung Disease
- Observational
- Ages 2 to 90
- All sexes
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00001532 · updated
Study of the Disease Process of Lymphangioleiomyomatosis
- Observational
- Ages 16 to 100
- All sexes
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00001465 · updated
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- Observational
- Ages 2 to 120
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT01730131 · updated
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- Observational
- Ages 18 to 120
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00001248 · updated
Study of Skin Tumors in Tuberous Sclerosis
- Observational
- Ages 18 to 90
- All sexes
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT00001975 · updated
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- Phase 1/2
- Ages 18 to 120
- All sexes
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT03109288 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Bethesda, MD on ClinicalTrials.gov.
Epilepsy studies recruiting in Bethesda
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Registry record
- NCT07563881 · updated
Tumor Related Epilepsy
- Observational
- Ages 8 to 99
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT02639325 · updated
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Phase 3
- Ages 4 to 55
- All sexes
- Sponsor
- SK Life Science, Inc.
- Study site
- Mid-Atlantic Epilepsy and Sleep Center
- Registry record
- NCT05219617 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Mid-Atlantic Epilepsy and Sleep Center
- Registry record
- NCT05667142 · updated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Mid-Atlantic Epilepsy and Sleep Center
- Registry record
- NCT05716100 · updated
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
- Phase 1
- Ages 18 to 60
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT02531880 · updated
Surgery as a Treatment for Medically Intractable Epilepsy
- Observational
- Ages 8 to 99
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT01273129 · updated
Investigating Epilepsy: Screening and Evaluation
- Observational
- Ages 8 to 110
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT03478852 · updated
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- Observational
- Ages 8 to 120
- All sexes
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study site
- National Institutes of Health Clinical Center
- Registry record
- NCT02107989 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Bethesda, MD on ClinicalTrials.gov.
Ask about studies near Bethesda
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Maryland
All Maryland locations
144 studies recruiting across 21 cities.
Baltimore
59 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections